Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane

Study Title
Efficacy and Safety Comparison of Albuterol Spiromaxֲ® and ProAirֲ® Hydrofluoroalkane (HFA) in Pediatric Patients
Teva Identifier
ABS-AS-202
ClinicalTrials.gov Identifier
NCT01899144
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Albuterol Spiromax | Drug: ProAir HFA | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
4 Years to 11 Years
Trial Duration
07/01/2013 - 10/01/2013
Phase
Phase 2

Study Type

Interventional